NASDAQ
IBEX
Last Price
US $30.37
KEY FIGURES
MKT CAP
$402.7M
EPS
TTM
$3.51
PEG
TTM
0.19x
P/E
TTM
8.55x
P/S
TTM
0.72x
YIELD
0.00%
GROWTH
Revenue Y/Y
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
IBEX Limited cash flow to debt ratio of 65.47% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.
Financial stability - Healthy cash flow growth.
IBEX Limited's free cash flow has increased 0.92% from $27.05M last year to $27.29M, signaling increasing performance
Financial stability - Healthy debt to equity ratio.
IBEX Limited's debt to equity ratio is 0.38, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial stability - Healthy debt to equity ratio development.
IBEX Limited's debt has decreased relative to shareholder equity from 0.40 last year to 0.38 today, signaling strengthened financials
Financial stability - Net debt/EBITDA.
IBEX Limited has a net debt to EBITDA ratio of 0.84x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
IBEX Limited's interest coverage ratio of 49.40 indicates that earnings with good margin can cover interest payments on company debt
Financial stability - Profit margin growth.
IBEX Limited's profit margin has increased (13.72%) in the last year from 6.62% to 7.53%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
IBEX Limited's short-term assets of $145.62M exceed its short-term liabilities of $79.94M
Increasing performance - ROA.
IBEX Limited's return on assets of 15.87% is higher than the 5.00% threshold, indicating efficient asset utilization
Increasing performance - Absolute return on equity.
IBEX Limited's return on equity of 31.81%, is higher than 15.00%, indicating good performance
Increasing performance - Earnings quality.
IBEX Limited's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
IBEX Limited had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
IBEX Limited has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
IBEX Limited has a free cash flow yield of 6.78%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
IBEX Limited's yearly earnings has increased 9.53% since last year from $33.66M to $36.86M, signaling increasing performance
Increasing performance - Healthy revenue growth.
IBEX Limited's yearly revenue has increased 9.77% since last year from $508.57M to $558.27M, signaling increasing performance
Increasing performance - ROIC.
ROIC 21.07% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
Increasing performance - 3-year revenue CAGR.
IBEX Limited's 3-year revenue CAGR of 4.24% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
IBEX Limited had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
IBEX Limited had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
IBEX Limited is overvalued relative to its fair value price of 10.90 based on Discounted Cash Flow model
Undervalued - Earnings yield.
IBEX Limited has an earnings yield of 11.66%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Overvalued - EBITDA valuation.
IBEX Limited is overvalued relative to its fair value price of 29.65 based on EBITDA multiple model
Undervalued - EV/EBITDA.
IBEX Limited has an EV/EBITDA ratio of 5.89x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Undervalued - PEG ratio value.
IBEX Limited has a PEG-ratio under 1 which is considered undervalued
Undervalued - P/B ratio.
IBEX Limited has a price-to-book ratio of 2.52x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
IBEX Limited has a price-to-sales ratio of 0.64x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
31.81%
Return on equity
ROIC: 21.07%
Valuation History
8.6X
Price to Earnings
EV/EBITDA: 5.9X
Cash flow
Profit margin
6.62%
(FY vs FY)
EBITDA Y/Y
8.31%
(FY vs FY)
Cash flow Y/Y
-10.47%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $30.37
-64.11%
Default assumptions
EBITDA Multiple
Fair Value
Market $30.37
-2.37%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.